Analysis of Off-label Use in Our Hospital in Nov. 2013

This paper analyzes the off-label use of drugs in our hospital in November 2013. The results show that off-label use of drugs exists objectively in clinical practice, most of which have pharmacological and literature basis, and there are also some potential drug risks; it is suggested to fully evaluate its safety and rationality, and improve the level of safe and rational drug use.


Analysis of Off-label Use in Our Hospital in Nov. 2013 - cover page
Category
Other
Document type
Other
Language
Chinese
Pages
4
File format
PDF
File size
784 KB
Published
16 November, 2023
Updated
16 November, 2023
MD5 checksum
AB6B9F99F57592F5BA10123F33790932

About this manual

This document is a research article published in the journal China Pharmacy, titled 'Analysis of Off-label Use in Our Hospital in Nov. 2013'. It presents a retrospective analysis of 11,000 prescriptions containing Chinese patent medicine, chemical drugs, or biological products prescribed in November 2013 at Liwan Hospital of Guangzhou Medical College.

The study identified 2,784 prescriptions (25.30%) and 4,307 medication orders (14.37%) as off-label use. The analysis categorized these instances by type, such as changing the route of administration (35.52%), insufficient dosage (19.53%), and inappropriate indications (12.17%). The authors concluded that while off-label use exists objectively and often has pharmacological basis, it carries risks and requires full evaluation of safety and rationality. This manual is written in Chinese.

What's inside

  • Objective
  • Methods
  • Results
  • Conclusions
  • General condition of off-label use
  • Common clinical diagnosed off-label use
  • Injection solvent usage
  • Chinese patent medicine combination
Download PDF (784 KB)

Also Manuals